Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Relmada Therapeutics (RLMD) Misses Q3 EPS by 84c

November 11, 2021 4:05 PM EST

Relmada Therapeutics (NASDAQ: RLMD) reported Q3 EPS of ($2.44), $0.84 worse than the analyst estimate of ($1.60).

As of September 30, 2021, the Company had cash and short-term investments of $88.1 million, compared to cash, cash equivalents, and short-term investments of approximately $117.1 million at December 31, 2021.

For earnings history and... More